. 2019 Aug 2;7:2324709619864989. doi: 10.1177/2324709619864989
© 2019 American Federation for Medical
Research
This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 3.
PET scan 3 months post-PARP inhibitor. No metastasis seen in the liver.